These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 844929)

  • 1. Blood and saliva salicylate measurement in the monitoring of salicylate therapy.
    Pérez-Mateo M; Erill S; Cabezas R
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration dependent plasma protein binding of salicylate in rheumatoid patients.
    Ekstrand R; Alvan G; Borga O
    Clin Pharmacokinet; 1979; 4(2):137-43. PubMed ID: 378501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbound plasma salicylate concentration in rheumatoid arthritis patients.
    Gurwich EL; Raees SM; Skosey J; Niazi S
    Br J Rheumatol; 1984 Feb; 23(1):66-73. PubMed ID: 6697076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protein binding of salicylates in rheumatoid arthritis].
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Pourel J; Faure G; Martin J; Gaucher A
    Rev Rhum Mal Osteoartic; 1982 May; 49(6):447-52. PubMed ID: 7112023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis.
    Levy G; Procknal JA; Olufs R; Pachman LM
    Clin Pharmacol Ther; 1980 May; 27(5):619-27. PubMed ID: 7371360
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma protein binding of salicylate and quinidine in patients with multiple myeloma.
    Perez-Mateo M; Erill S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):168-70. PubMed ID: 447437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of serum salicylate determination in patients with rheumatoid arthritis (author's transl)].
    Lan JL; Wong W; Wang WC; Wu HS; Chen HL; Han SH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Mar; 13(1):27-32. PubMed ID: 7449520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on the use of salicylate saliva concentration in clinical pharmacokinetic studies.
    Khan AZ; Aarons L
    J Pharm Pharmacol; 1989 Oct; 41(10):710-1. PubMed ID: 2575150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability to interpret toxic salicylate levels in patients taking aspirin and diflunisal.
    Adelman HM; Wallach PM; Flannery MT
    J Rheumatol; 1991 Apr; 18(4):522-3. PubMed ID: 2066942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.
    Tugwell P; Hart L; Kraag G; Park A; Dok C; Bianchi F; Goldsmith C; Buchanan WW
    J Rheumatol; 1984 Aug; 11(4):457-61. PubMed ID: 6481719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Urich AW; Goatcher PM
    Med J Aust; 1970 Oct; 2(14):653-4. PubMed ID: 5477813
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Brick DL; Corrigan AB
    Med J Aust; 1970 Aug; 2(8):382-3. PubMed ID: 5457655
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
    Cham BE; Bochner F; Imhoff DM; Byrne G; Gunsberg M
    J Pharmacol Exp Ther; 1982 Mar; 220(3):648-53. PubMed ID: 7062274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylate toxicity in elderly patients with rheumatoid arthritis.
    Grigor RR; Spitz PW; Furst DE
    J Rheumatol; 1987 Feb; 14(1):60-6. PubMed ID: 3572936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
    Cleland LG; Lowthian PJ; Imhoff D; Bochner F; Betts WH; O'Callaghan J
    J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Faure G; Pourel J; Martin J; Gaucher A
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):109-16. PubMed ID: 6745302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength.
    Keystone EC; Paton TW; Littlejohn G; Verdejo A; Piper S; Wright LA; Goldsmith CH
    Can Med Assoc J; 1982 Aug; 127(4):283-6. PubMed ID: 7093867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?
    Halla JT; Atchison SL; Hardin JG
    Ann Rheum Dis; 1991 Oct; 50(10):682-4. PubMed ID: 1958090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.